Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 PatientsSander F. Garrelfs, Michiel J.S. Oosterveld, Henk Schierbeek et al.|Journal of the American Society of Nephrology|2021Cited by 21
Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1Sander F. Garrelfs, Michiel J.S. Oosterveld, Elisabeth L. Metry et al.|Kidney International|2023Cited by 13
Development and Validation of a New Gas Chromatography–Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope ProcedureDewi van Harskamp, Henk Schierbeek, Sander F. Garrelfs et al.|Analytical Chemistry|2019Cited by 12
Understanding Gastrointestinal Oxalate Metabolism in Kidney Stone Disease: A Stable Isotope StudyLisa J. Deesker, Jaap W. Groothoff, Tim de Meij et al.|Journal of the American Society of Nephrology|2024Cited by 0